Literature DB >> 24246365

Heparin-protein interactions: from affinity and kinetics to biological roles. Application to an interaction network regulating angiogenesis.

Franck Peysselon1, Sylvie Ricard-Blum2.   

Abstract

Numerous extracellular proteins, growth factors, chemokines, cytokines, enzymes, lipoproteins, involved in a variety of biological processes, interact with heparin and/or heparan sulfate at the cell surface and in the extracellular matrix (ECM). The goal of this study is to investigate the relationship(s) between affinity and kinetics of heparin-protein interactions and the localization of the proteins, their intrinsic disorder and their biological roles. Most proteins bind to heparin with a higher affinity than their fragments and form more stable complexes with heparin than with heparan sulfate. Lipoproteins and matrisome-associated proteins (e.g. growth factors and cytokines) bind to heparin with very high affinity. Matrisome-associated proteins form transient complexes with heparin. However they bind to this glycosaminoglycan with a higher affinity than the proteins of the core matrisome, which contribute to ECM assembly and organization, and than the secreted proteins which are not associated with the ECM. The association rate of proteins with heparin is related to the intrinsic disorder of heparin-binding sites. Enzyme inhibitor activity, protein dimerization, skeletal system development and pathways in cancer are functionally associated with proteins displaying a high or very high affinity for heparin (KD<100 nM). Besides their use in investigating molecular recognition and functions, kinetics and affinity are essential to prioritize interactions in networks and to build network models as discussed for the interaction network established at the surface of endothelial cells by endostatin, a heparin-binding protein regulating angiogenesis.
Copyright © 2013 International Society of Matrix Biology. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Affinity; Angiogenesis; Heparin–protein interactions; Interaction network; Intrinsic disorder; Kinetics

Mesh:

Substances:

Year:  2013        PMID: 24246365     DOI: 10.1016/j.matbio.2013.11.001

Source DB:  PubMed          Journal:  Matrix Biol        ISSN: 0945-053X            Impact factor:   11.583


  41 in total

1.  Decellularized neonatal cardiac extracellular matrix prevents widespread ventricular remodeling in adult mammals after myocardial infarction.

Authors:  Zhouguang Wang; Daniel W Long; Yan Huang; William C W Chen; Kang Kim; Yadong Wang
Journal:  Acta Biomater       Date:  2019-01-30       Impact factor: 8.947

Review 2.  Glycosaminoglycanomics: where we are.

Authors:  Sylvie Ricard-Blum; Frédérique Lisacek
Journal:  Glycoconj J       Date:  2016-11-30       Impact factor: 2.916

Review 3.  The role of perlecan and endorepellin in the control of tumor angiogenesis and endothelial cell autophagy.

Authors:  Stephen Douglass; Atul Goyal; Renato V Iozzo
Journal:  Connect Tissue Res       Date:  2015-07-16       Impact factor: 3.417

4.  Endorepellin-evoked Autophagy Contributes to Angiostasis.

Authors:  Atul Goyal; Maria A Gubbiotti; Daphney R Chery; Lin Han; Renato V Iozzo
Journal:  J Biol Chem       Date:  2016-07-19       Impact factor: 5.157

5.  2-O, 3-O Desulfated Heparin Blocks High Mobility Group Box 1 Release by Inhibition of p300 Acetyltransferase Activity.

Authors:  Shuo Zheng; Apparao B Kummarapurugu; Daniel K Afosah; Nehru Viji Sankaranarayanan; Rio S Boothello; Umesh R Desai; Thomas Kennedy; Judith A Voynow
Journal:  Am J Respir Cell Mol Biol       Date:  2017-01       Impact factor: 6.914

6.  Microparticle-mediated sequestration of cell-secreted proteins to modulate chondrocytic differentiation.

Authors:  Torri E Rinker; Brandon D Philbrick; Marian H Hettiaratchi; David M Smalley; Todd C McDevitt; Johnna S Temenoff
Journal:  Acta Biomater       Date:  2017-12-30       Impact factor: 8.947

7.  High resolution structure of human apolipoprotein (a) kringle IV type 2: beyond the lysine binding site.

Authors:  Alice Santonastaso; Maristella Maggi; Hugo De Jonge; Claudia Scotti
Journal:  J Lipid Res       Date:  2020-09-09       Impact factor: 5.922

Review 8.  The role of heparins and nano-heparins as therapeutic tool in breast cancer.

Authors:  Nikos A Afratis; Konstantina Karamanou; Zoi Piperigkou; Demitrios H Vynios; Achilleas D Theocharis
Journal:  Glycoconj J       Date:  2016-10-24       Impact factor: 2.916

Review 9.  Heparan sulfate and heparin interactions with proteins.

Authors:  Maria C Z Meneghetti; Ashley J Hughes; Timothy R Rudd; Helena B Nader; Andrew K Powell; Edwin A Yates; Marcelo A Lima
Journal:  J R Soc Interface       Date:  2015-09-06       Impact factor: 4.118

10.  Evaluation of top-down mass spectrometry and ion-mobility spectroscopy as a means of mapping protein-binding motifs within heparin chains.

Authors:  Yunlong Zhao; Igor A Kaltashov
Journal:  Analyst       Date:  2020-04-14       Impact factor: 4.616

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.